9月30日，Hims & Hers Health盘中上涨5.03%，报30.145美元/股，成交额6985.01万美元。
消息面上，公司近日推出全新AI驱动的应用程序体验，目前面向减重会员开放，该系统利用治疗历史与结果构建反馈循环，持续优化个性化护理方案。此前公司曾表示AI投资有望在12至18个月内实现自我回报。此外，公司当前空头持仓占流通股比例高达26.69%，在股价突破30美元关口后，空头回补压力或进一步放大涨幅。
基本面方面，Truist近期将目标价由27美元上调至32美元，维持持有评级；公司Q2营收7.53亿美元，同比增长38%，全年营收指引上调至31亿至33亿美元，国内业务下半年有望持续加速。
Hims & Hers Health Inc是一家多专业远程医疗平台，将消费者与持牌医疗保健专业人员联系起来，提供心理健康、性健康、皮肤病学、头发护理等多领域医疗服务。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.